Skip to content

Inside DNAnexus

Product updates, industry insights, opinions and references. From the team powering the Genomics Revolution.

Our Commitment to our Customers and Partners During Coronavirus (COVID-19)

Coronavirus Statement

At DNAnexus, customer success is one of our core values and we take pride in delivering a high level of quality and reliability. With the current situation, we wanted to share with you the steps we have taken for the coronavirus (COVID-19) outbreak.

Today, we have no impact nor do we foresee any impacts to the delivery of the DNAnexus Platform and Services. Our cloud-based, multi-tenant architecture and fault-tolerant approach is designed to operate without any service disruptions. Moreover, we have a distributed, highly-skilled workforce committed to supporting the customers and partners around the globe.

Many of you are examining your own preparations to ensure continuation of your work during COVID-19. In the spirit of transparency, we are sharing our plans to ensure the health and safety of members of the DNAnexus community, including our employees, customers and partners.

Travel and Remote Work

To limit the risk of exposure and spread of COVID-19, we have restricted travel for our employees and contractors. We are committed to provide the highest levels of service and engagement through online means and telecommunications.

In addition, we have closed our offices and our employees and contractors are working remotely from home. As a global, cloud-based company, DNAnexus people frequently work from anywhere, and have the resources and tools they need to perform their jobs securely from any location.

Service and Operations

Our cloud service is designed with a high degree of redundancy and fail-over capabilities to reduce the likelihood of significant impact due to an emergency or crisis. We have developed, maintained, and trained our personnel in the policies and procedures for responding to these events, including disaster recovery plans that are part of our FedRAMP Moderate Authority-To-Operate (ATO), our ISO27001 certification, and our HITRUST program.

We continue to closely monitor and consider recommendations from the World Health Organization (WHO), the Centers for Disease Control (CDC), and government and health officials where our employees live and work.

We will stay in touch to keep you updated. Thank you for our continued trust in DNAnexus. If you have any questions or concerns, please do not hesitate to contact us at support@dnanexus.com.

Regards,

Richard Daly
CEO
DNAnexus

About DNAnexus

DNAnexus the leader in biomedical informatics and data management, has created the global network for genomics and other biomedical data, operating in 33 countries including North America, Europe, China, Australia, South America, and Africa. The secure, scalable, and collaborative DNAnexus Platform helps thousands of researchers across a spectrum of industries — biopharmaceutical, bioagricultural, sequencing services, clinical diagnostics, government, and research consortia — accelerate their genomics programs.

The DNAnexus team is made up of experts in computational biology and cloud computing who work with organizations to tackle some of the most exciting opportunities in human health, making it easier—and in many cases feasible—to work with genomic data. With DNAnexus, organizations can stay a step ahead in leveraging genomics to achieve their goals. The future of human health is in genomics. DNAnexus brings it all together.